Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · IEX Real-Time Price · USD
7.53
+0.09 (1.21%)
At close: Mar 28, 2024, 4:00 PM
7.39
-0.14 (-1.86%)
After-hours: Mar 28, 2024, 7:21 PM EDT

Health Catalyst Stock Forecast

Stock Price Forecast

The 12 analysts with 12-month price forecasts for Health Catalyst stock have an average target of 12.92, with a low estimate of 8.00 and a high estimate of 16. The average target predicts an increase of 71.58% from the current stock price of 7.53.

Analyst Consensus: Buy
Target Low Average Median High
Price $8.00 $12.92 $14 $16
Change +6.24% +71.58% +85.92% +112.48%

Analyst Ratings

The average analyst rating for HCAT stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Oct '23Nov '23Dec '23Jan '24Feb '24Mar '24
Strong Buy 222333
Buy 445667
Hold 455333
Sell 000000
Strong Sell 000000
Total 101112121213

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$16
Buy Reiterates $16 +112.48% Mar 5, 2024
Keybanc
Keybanc
Buy
Maintains
$12$10
Buy Maintains $12$10 +32.80% Feb 26, 2024
Piper Sandler
Piper Sandler
Buy
Reiterates
$17$15
Buy Reiterates $17$15 +99.20% Feb 23, 2024
Evercore ISI Group
Evercore ISI Group
Buy
Maintains
$11$10
Buy Maintains $11$10 +32.80% Feb 23, 2024
Canaccord Genuity
Canaccord Genuity
Strong Buy
Maintains
$12$11
Strong Buy Maintains $12$11 +46.08% Feb 23, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
316.23M
from 295.94M
Increased by 6.86%
Revenue Next Year
352.49M
from 316.23M
Increased by 11.47%
EPS This Year
0.32
from -2.09
EPS Next Year
0.52
from 0.32
Increased by 61.06%
Year 20192020202120222023202420252026
Revenue
154.94M188.85M241.93M276.24M295.94M316.23M352.49M409.47M
Revenue Growth
37.63%21.88%28.11%14.18%7.13%6.86%11.47%16.16%
EPS
-12.86-2.91-3.23-2.63-2.090.320.520.90
EPS Growth
------61.06%74.16%
No. Analysts -----18184
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High 347.6M 370.7M 453.6M
Avg 316.2M 352.5M 409.5M
Low 299.9M 331.0M 377.3M

Revenue Growth

Revenue Growth 202420252026
High
17.4%
17.2%
28.7%
Avg
6.9%
11.5%
16.2%
Low
1.3%
4.7%
7.0%

EPS Forecast

EPS 202420252026
High 0.47 0.68 0.96
Avg 0.32 0.52 0.90
Low -0.01 0.34 0.83

EPS Growth

EPS Growth 202420252026
High -
113.0%
85.6%
Avg -
61.1%
74.2%
Low -
7.1%
61.4%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.